Vernakalant (Proposed Name, US: Kynapid™; Brinavess™ [Europe])

An intravenous antiarrhythmic for the conversion of recent onset atrial fibrillation to sinus rhythm. 

If you have a Hayes login, click here to view the full report on the Knowledge Center.